(Q46782495)

25 December 2017

title

Citicoline inhibits MAP kinase signalling pathways after focal cerebral ischaemia (English)

1 reference

25 December 2017

1 reference

3

1 reference

25 December 2017

author name string

J Krupinski

series ordinal

1

1 reference

25 December 2017

M Slevin

series ordinal

2

1 reference

25 December 2017

publication date

1 August 2005

1 reference

25 December 2017

published in

Neurochemical Research

1 reference

25 December 2017

volume

30

1 reference

25 December 2017

issue

8

1 reference

25 December 2017

page(s)

1067-1073

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s11064-005-7201-0

exact match

0 references

cites work

A randomized efficacy trial of citicoline in patients with acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-005-7201-0

A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-005-7201-0

Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-005-7201-0

Histologic assessment of neurons in rat models of cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-005-7201-0

Components of a new human protein kinase signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-005-7201-0

A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-005-7201-0

Transducing signals of life and death

21 January 2018

1 reference

12 December 2020

Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport

1 reference

12 December 2020

Neuroprotective agent chlomethiazole attenuates c-fos, c-jun, and AP-1 activation through inhibition of p38 MAP kinase

1 reference

12 December 2020

Activation of p38MAPK in microglia after ischemia.

1 reference

12 December 2020

Mitogen-activated protein kinase pathways

1 reference

12 December 2020

Citicoline mechanisms and clinical efficacy in cerebral ischemia

1 reference

12 December 2020

Protein kinase cascades activated by stress and inflammatory cytokines

1 reference

12 December 2020

Neuronal protein kinase signaling cascades and excitotoxic cell death

1 reference

12 December 2020

Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism.

1 reference

12 December 2020

Time-course phosphorylation of the mitogen activated protein (MAP) kinase group of signalling proteins and related molecules following middle cerebral artery occlusion (MCAO) in rats

1 reference

12 December 2020

Tumor necrosis factor-alpha inhibits expression of CTP:phosphocholine cytidylyltransferase.

1 reference

12 December 2020

Betaine generation in cardiac myocytes after adrenergic activation of phosphatidylcholine hydrolysis

1 reference

12 December 2020

Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia

1 reference

12 December 2020

Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials

1 reference

12 December 2020

Effect of cytidine diphosphate choline (CDP-choline) on ischemia-induced alterations of brain lipid in the gerbil

1 reference

12 December 2020

Expression of interleukin-1 beta converting enzyme gene family and bcl-2 gene family in the rat brain following permanent occlusion of the middle cerebral artery.

1 reference

12 December 2020

Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat

1 reference

12 December 2020

The effects of prolonged treatment with citicoline in temporary experimental focal ischemia

1 reference

12 December 2020

Phosphatidylcholine metabolism in nuclei of phorbol ester-activated LA-N-1 neuroblastoma cells

1 reference

12 December 2020

Citicoline for treatment of experimental focal ischemia: histologic and behavioral outcome.

1 reference

12 December 2020

Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke

1 reference

12 December 2020

Does CDP-choline modulate phospholipase activities after transient forebrain ischemia?

1 reference

12 December 2020

Transcriptional responses to polypeptide ligands: the JAK-STAT pathway

1 reference

12 December 2020

Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline

1 reference

12 December 2020

10.1007/S11064-005-7201-0

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16258856

1 reference

25 December 2017